company background image
STXS logo

Stereotaxis NYSEAM:STXS Stock Report

Last Price

US$2.22

Market Cap

US$203.8m

7D

-3.1%

1Y

14.4%

Updated

11 Jun, 2025

Data

Company Financials +

Stereotaxis (STXS) Stock Overview

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More details

STXS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

STXS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

US$4.50
FV
50.7% undervalued intrinsic discount
40.71%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
about 11 hours ago author updated this narrative

Stereotaxis, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Stereotaxis
Historical stock prices
Current Share PriceUS$2.22
52 Week HighUS$2.72
52 Week LowUS$1.54
Beta1.46
1 Month Change7.25%
3 Month Change24.72%
1 Year Change14.43%
3 Year Change15.03%
5 Year Change-58.11%
Change since IPO-97.16%

Recent News & Updates

author-image

Robotics And Digital Surgery Will Open New Frontiers

Strategic initiatives in robotics, digital surgery, and acquisitions might boost revenue, market size, and net margins through innovation and market expansion.

Recent updates

author-image

Robotics And Digital Surgery Will Open New Frontiers

Strategic initiatives in robotics, digital surgery, and acquisitions might boost revenue, market size, and net margins through innovation and market expansion.

US$9.33 - That's What Analysts Think Stereotaxis, Inc. (NYSEMKT:STXS) Is Worth After These Results

Feb 28
US$9.33 - That's What Analysts Think Stereotaxis, Inc. (NYSEMKT:STXS) Is Worth After These Results

Is Stereotaxis (NYSEMKT:STXS) A Risky Investment?

Jan 28
Is Stereotaxis (NYSEMKT:STXS) A Risky Investment?

Shareholder Returns

STXSUS Medical EquipmentUS Market
7D-3.1%-0.6%1.2%
1Y14.4%6.9%11.2%

Return vs Industry: STXS exceeded the US Medical Equipment industry which returned 8.2% over the past year.

Return vs Market: STXS exceeded the US Market which returned 12.8% over the past year.

Price Volatility

Is STXS's price volatile compared to industry and market?
STXS volatility
STXS Average Weekly Movement8.6%
Medical Equipment Industry Average Movement8.8%
Market Average Movement7.7%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market4.0%

Stable Share Price: STXS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: STXS's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990139David Fischelwww.stereotaxis.com

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems.

Stereotaxis, Inc. Fundamentals Summary

How do Stereotaxis's earnings and revenue compare to its market cap?
STXS fundamental statistics
Market capUS$203.77m
Earnings (TTM)-US$26.65m
Revenue (TTM)US$27.51m
6.9x
P/S Ratio
-7.2x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STXS income statement (TTM)
RevenueUS$27.51m
Cost of RevenueUS$12.82m
Gross ProfitUS$14.69m
Other ExpensesUS$41.34m
Earnings-US$26.65m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.31
Gross Margin53.41%
Net Profit Margin-96.88%
Debt/Equity Ratio0%

How did STXS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/11 07:12
End of Day Share Price 2025/06/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stereotaxis, Inc. is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charley JonesBarrington Research Associates, Inc.
Neil ChatterjiB. Riley Securities, Inc.
Jose De Jesus HarescoCitizens JMP Securities, LLC